The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Enhancing the vascularization of three‐dimensional porous alginate scaffolds by incorporating controlled release basic fibroblast growth factor microspheres
Abstract
Site‐specific delivery of angiogenic growth factors from tissue‐engineered devices should provide an efficient means of stimulating localized vessel recruitment to the cell transplants and would ensure cell survival and function. In the present article, we describe the construction of a novel porous alginate scaffold that incorporates tiny poly (lactic‐co‐glycolic acid) microspheres capable of controlling the release of angiogenic factors, such as basic fibroblast growth factor (bFGF). The microspheres are an integral part of the solid alginate matrix, and their incorporation does not affect the scaffold porosity or pore size. In vitro, bFGF was released from the porous composite scaffolds in a controlled manner and it was biologically active as assessed by its ability to induce the proliferation of cardiac fibroblasts. The controlled delivery of bFGF from the three‐dimensional scaffolds accelerated the matrix vascularization after implantation on the mesenteric membrane in rat peritoneum. The number of penetrating capillaries into the bFGF‐releasing scaffolds was nearly fourfold higher than into the control scaffolds (those incorporating microspheric BSA and heparin but not bFGF). At day 10 posttransplantation, capillary density in the composite scaffolds was 45 ± 3/mm 2 and it increased to 70 ± 7/mm 2 by day 21. The released bFGF induced the formation of large and matured blood vessels, as judged by the massive layer of mural cells surrounding the endothelial cells. The control over bFGF delivery and localizing its effects to areas of need, may aid in the wider application of bFGF in therapeutic angiogenesis as well as in tissue engineering. © 2003 Wiley Periodicals, Inc. J Biomed Mater Res 65A: 489–497, 2003
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Langer, R., & Vacanti, J. P. (1993) · Science · doi:10.1126/science.8493529 · Cited by 9,893
THE HEPARIN-BINDING (FIBROBLAST) GROWTH FACTOR FAMILY OF PROTEINS
Burgess, W. H., & Maciag, T. (1989) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.58.070189.003043 · Cited by 1,928
Polymeric system for dual growth factor delivery
Richardson, T. P., Peters, M. C., Ennett, A. B., & Mooney, D. J. (2001) · Nature Biotechnology · doi:10.1038/nbt1101-1029 · Cited by 1,752
Leakage-Resistant Blood Vessels in Mice Transgenically Overexpressing Angiopoietin-1
Thurston, G., Suri, C., Smith, K., McClain, J., Sato, T. N., Yancopoulos, G. D., & McDonald, D. M. (1999) · Science · doi:10.1126/science.286.5449.2511 · Cited by 1,359
Vacanti, J. P., & Langer, R. (1999) · The Lancet · doi:10.1016/s0140-6736(99)90247-7 · Cited by 1,323
Structural Characterization and Biological Functions of Fibroblast Growth Factor
GOSPODAROWICZ, D., FERRARA, N., SCHWEIGERER, L., & NEUFELD, G. (1987) · Endocrine Reviews · doi:10.1210/edrv-8-2-95 · Cited by 1,273
Self-citationBenjamin, L. E., Hemo, I., & Keshet, E. (1998) · Development · doi:10.1242/dev.125.9.1591 · Cited by 1,265
Heparin protects basic and acidic FGF from inactivation
Gospodarowicz, D., & Cheng, J. (1986) · Journal of Cellular Physiology · doi:10.1002/jcp.1041280317 · Cited by 853
Controlled Delivery Systems for Proteins Based on Poly(Lactic/Glycolic Acid) Microspheres
Cohen, S., Yoshioka, T., Lucarelli, M., Hwang, L. H., & Langer, R. (1991) · Pharmaceutical Research · doi:10.1023/a:1015841715384 · Cited by 843
Self-citationImplantable biohybrid artificial organs
Colton, C. (1995) · Cell Transplantation · doi:10.1016/0963-6897(95)00025-s · Cited by 586
Cited by
Mano, J. F., Silva, G. A., Azevedo, H. S., Malafaya, P. B., Sousa, R. A., Silva, S. S., Boesel, L. F., Oliveira, J. M., Santos, T. C., Marques, A. P., et al. (2007) · Journal of The Royal Society Interface · doi:10.1098/rsif.2007.0220 · Cited by 1,140
Vascularization is the key challenge in tissue engineering
Novosel, E. C., Kleinhans, C., & Kluger, P. J. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.03.004 · Cited by 1,062
Vascularization Strategies for Tissue Engineering
Lovett, M., Lee, K., Edwards, A., & Kaplan, D. L. (2009) · Tissue Engineering Part B: Reviews · doi:10.1089/ten.teb.2009.0085 · Cited by 923
Liu, Z., Meyers, M. A., Zhang, Z., & Ritchie, R. O. (2017) · Progress in Materials Science · doi:10.1016/j.pmatsci.2017.04.013 · Cited by 895
Fibroblast Growth Factors: Biology, Function, and Application for Tissue Regeneration
Yun, Y.-R., Won, J. E., Jeon, E., Lee, S., Kang, W., Jo, H., Jang, J.-H., Shin, U. S., & Kim, H.-W. (2010) · Journal of Tissue Engineering · doi:10.4061/2010/218142 · Cited by 712
Dynamic reassembly of peptide RADA16 nanofiber scaffold
Yokoi, H., Kinoshita, T., & Zhang, S. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407843102 · Cited by 679
3D Cell Culture Systems: Tumor Application, Advantages, and Disadvantages
Habanjar, O., Diab-Assaf, M., Caldefie-Chezet, F., & Delort, L. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222212200 · Cited by 547
Angiogenesis in Tissue Engineering: Breathing Life into Constructed Tissue Substitutes
Laschke, M. W., Harder, Y., Amon, M., Martin, I., Farhadi, J., Ring, A., Torio-Padron, N., Schramm, R., Rücker, M., Junker, D., et al. (2006) · Tissue Engineering · doi:10.1089/ten.2006.12.2093 · Cited by 546
Controlled Growth Factor Delivery for Tissue Engineering
Tayalia, P., & Mooney, D. J. (2009) · Advanced Materials · doi:10.1002/adma.200900241 · Cited by 430
Controlled drug delivery in tissue engineering
Biondi, M., Ungaro, F., Quaglia, F., & Netti, P. A. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.08.038 · Cited by 412
Surface engineered and drug releasing pre-fabricated scaffolds for tissue engineering
Chung, H. J., & Park, T. G. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.03.015 · Cited by 401
Naturally derived materials-based cell and drug delivery systems in skin regeneration
Huang, S., & Fu, X. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.10.018 · Cited by 390
Unger, R. E., Sartoris, A., Peters, K., Motta, A., Migliaresi, C., Kunkel, M., Bulnheim, U., Rychly, J., & James Kirkpatrick, C. (2007) · Biomaterials · doi:10.1016/j.biomaterials.2007.05.032 · Cited by 385
Biomaterials in cardiac tissue engineering: Ten years of research survey
Chen, Q.-Z., Harding, S. E., Ali, N. N., Lyon, A. R., & Boccaccini, A. R. (2008) · Materials Science and Engineering: R: Reports · doi:10.1016/j.mser.2007.08.001 · Cited by 382
Tallawi, M., Rosellini, E., Barbani, N., Cascone, M. G., Rai, R., Saint-Pierre, G., & Boccaccini, A. R. (2015) · Journal of The Royal Society Interface · doi:10.1098/rsif.2015.0254 · Cited by 366
Cells, scaffolds, and molecules for myocardial tissue engineering
Leor, J., Amsalem, Y., & Cohen, S. (2005) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2004.10.003 · Cited by 344
Self-citationVascularization—The Conduit to Viable Engineered Tissues
Kaully, T., Kaufman-Francis, K., Lesman, A., & Levenberg, S. (2009) · Tissue Engineering Part B: Reviews · doi:10.1089/ten.teb.2008.0193 · Cited by 317
Glicklis, R., Merchuk, J. C., & Cohen, S. (2004) · Biotechnology and Bioengineering · doi:10.1002/bit.20086 · Cited by 316
“At present, we are exploring different approaches, such as prevascularization of the scaffolds before cell seeding (Perets et al., 2003) and the design of a scaffold with an axial and radial nutrient diffusion to enable thick implants.”
MethodSelf-citationAdvances in tissue engineering
Langer, R., & Vacanti, J. (2016) · Journal of Pediatric Surgery · doi:10.1016/j.jpedsurg.2015.10.022 · Cited by 316
Advanced biomaterials for skeletal tissue regeneration: Instructive and smart functions
Barrère, F., Mahmood, T. A., de Groot, K., & van Blitterswijk, C. A. (2008) · Materials Science and Engineering: R: Reports · doi:10.1016/j.mser.2007.12.001 · Cited by 303
Shen, Y. H., Shoichet, M. S., & Radisic, M. (2008) · Acta Biomaterialia · doi:10.1016/j.actbio.2007.12.011 · Cited by 289
Microfluidic techniques for development of 3D vascularized tissue
Hasan, A., Paul, A., Vrana, N. E., Zhao, X., Memic, A., Hwang, Y.-S., Dokmeci, M. R., & Khademhosseini, A. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.04.091 · Cited by 282
Culture media for the differentiation of mesenchymal stromal cells
Vater, C., Kasten, P., & Stiehler, M. (2011) · Acta Biomaterialia · doi:10.1016/j.actbio.2010.07.037 · Cited by 279
Alginate: Enhancement Strategies for Advanced Applications
Hurtado, A., Aljabali, A. A. A., Mishra, V., Tambuwala, M. M., & Serrano-Aroca, Á. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23094486 · Cited by 275
Growth Factor Delivery Approaches in Hydrogels
Silva, A. K. A., Richard, C., Bessodes, M., Scherman, D., & Merten, O.-W. (2009) · Biomacromolecules · doi:10.1021/bm801103c · Cited by 274
Bioactive Materials for Bone Regeneration: Biomolecules and Delivery Systems
Szwed-Georgiou, A., Płociński, P., Kupikowska-Stobba, B., Urbaniak, M. M., Rusek-Wala, P., Szustakiewicz, K., Piszko, P., Krupa, A., Biernat, M., Gazińska, M., et al. (2023) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.3c00609 · Cited by 269
Jeon, O., Song, S. J., Kang, S.-W., Putnam, A. J., & Kim, B.-S. (2007) · Biomaterials · doi:10.1016/j.biomaterials.2007.02.023 · Cited by 261
Freeman, I., & Cohen, S. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2008.12.057 · Cited by 252
Self-citationWang, X., Sun, Q., & Pei, J. (2018) · Micromachines · doi:10.3390/mi9100493 · Cited by 106
Cell-Seeded Biomaterial Scaffolds: The Urgent Need for Unanswered Accelerated Angiogenesis
Shokrani, H., Shokrani, A., Sajadi, S. M., Seidi, F., Mashhadzadeh, A. H., Rabiee, N., Saeb, M. R., Aminabhavi, T., & Webster, T. J. (2022) · International Journal of Nanomedicine · doi:10.2147/ijn.s353062 · Cited by 48
Metadata
- Authors
- Perets, A., Baruch, Y., Weisbuch, F., Shoshany, G., Neufeld, G., & Cohen, S.
- Venue
- Journal of Biomedical Materials Research Part A
- Publisher
- Wiley
- Published
- 2003-05-13
- Volume
- 65A
- Issue
- 4
- Pages
- 489-497
- ISSN
- 1549-3296 (ISSN-L)
- 1552-4965
- OpenAlex
- W2154303934
- Cited by
- 439
- References
- 30
- FWCI
- 20.06
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.